Literature DB >> 12730919

Glucosamine and chondroitin sulfate are effective in the management of osteoarthritis.

David S Hungerford1, Lynne C Jones.   

Abstract

The use of glucosamine and chondroitin sulfate for the symptomatic treatment of osteoarthritis has been a subject of controversy for several reasons. First, the medical community in general took offense at the title of Theodosakis' book, The Arthritis Cure. Second, the medical community is becoming divided into "traditional" and "alternative" camps with deep skepticism between them. Third, the whole nutraceutical industry is essentially unregulated, with manufacturers making outrageous claims on products that have never been tested at all, are often of poor quality, and occasionally lacking in any active ingredient. However, for the nutriceuticals evaluated here, there is abundant in vitro, in vivo, animal clinical, and human clinical evidence of both their efficacy and safety. They deserve a prominent place in the armamentarium of nonsurgical treatment of osteoarthritis. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730919     DOI: 10.1054/arth.2003.50067

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

Review 1.  Immunological activity of chondroitin sulfate.

Authors:  Toshihiko Toida; Shinobu Sakai; Hiroshi Akiyama; Robert J Linhardt
Journal:  Adv Pharmacol       Date:  2006

2.  Glucosamine and chondroitin sulfate association increases tibial epiphyseal growth plate proliferation and bone formation in ovariectomized rats.

Authors:  Roberta Bastos Wolff
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

3.  The Identified Hub Gene GlcN in Osteoarthritis Progression and Treatment.

Authors:  Jingsheng Liu; Xiaoli Dong; Yining Liu; Kai Wang; Shuanhu Lei; Mingxuan Yang; Haiyuan Yue; Haijun Feng; Kai Feng; Kang Li; Jianwei Zhou; Yanqiang Chen; Wenjia Du; Xuewen Kang; Yayi Xia
Journal:  Comput Math Methods Med       Date:  2021-10-31       Impact factor: 2.238

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.